VistaGen Therapeutics Long Term Debt Current 2011-2026 | VTGN

Annual Long Term Debt Current VistaGen Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
561 K	550 K	486 K	433 K	365 K	313 K	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
561 K	313 K	451 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer	Long Term Debt Current	Price	% 24h	Market Cap	Country
Scholar Rock Holding Corporation SRRK	5.55 M	$ 43.62	-1.33 %	$ 5 B	USA
MorphoSys AG MOR	3.63 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	213 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	271 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	181 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	625 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	410 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	671 K	-	0.23 %	$ 488 M	USA
I-Mab IMAB	8.06 M	-	-	$ 866 M	China
Albireo Pharma ALBO	3.08 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	48 K	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	337 K	-	-39.0 %	$ 4.57 M	USA
Applied Genetic Technologies Corporation AGTC	1.27 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	419 K	-	-	$ 7.46 M	Israel
Atreca BCEL	3.54 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	1.59 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	21.2 M	-	-	$ 546 M	USA
Acasti Pharma ACST	75 K	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	1.35 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	5.67 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	104 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	166 K	-	-9.65 %	$ 45.9 M	USA
Stoke Therapeutics STOK	3.01 M	$ 33.98	0.83 %	$ 2.01 B	USA
Autolus Therapeutics plc AUTL	5.05 M	$ 1.23	-5.04 %	$ 314 M	Britain
EyePoint Pharmaceuticals EYPT	2.02 M	$ 13.09	0.23 %	$ 959 K	USA
BeiGene, Ltd. BGNE	20.7 M	-	0.49 %	$ 251 B	Cayman-islands
Cara Therapeutics CARA	1.92 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	2.81 M	-	-	$ 3.74 B	USA
Enochian Biosciences ENOB	313 K	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	3.47 M	-	-	$ 867 M	Germany
Equillium EQ	363 K	$ 2.06	-	$ 118 M	USA
Theravance Biopharma TBPH	10.9 M	$ 14.97	-1.45 %	$ 753 M	Cayman-islands
Eton Pharmaceuticals ETON	65 K	$ 23.43	-0.09 %	$ 630 M	USA
Bellerophon Therapeutics BLPH	203 K	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	18.6 M	$ 47.18	-0.79 %	$ 4.24 B	Schweiz
Arbutus Biopharma Corporation ABUS	547 K	$ 4.46	0.22 %	$ 855 M	Canada
Allakos ALLK	3.25 M	-	-	$ 28.6 M	USA